MyLRC +
Administrative Rules
Rule 44:22:02 REPORTING REQUIREMENTS

CHAPTER 44:22:02

REPORTING REQUIREMENTS

 

Section

44:22:02:01                           Entities required to provide report.

44:22:02:02                           Reportable conditions -- General criteria.

44:22:02:03 to 44:22:02:05    Repealed.

44:22:02:06                           Reportable data elements for tumor registries.

44:22:02:07                           Method of reporting for tumor registries.

44:22:02:08                           Repealed.

44:22:02:09                           Method of reporting for pathology laboratories.

44:22:02:09.01                      Method of reporting for hospitals without tumor registries, physicians, physician assistants, nurse practitioners, nurse midwives, and free-standing radiology centers.

44:22:02:10                           Reporting for other entities.




Rule 44:22:02:01 Entities required to provide report.

          44:22:02:01.  Entities required to provide report. Any hospital, physician, physician assistant, nurse practitioner, or nurse midwife, pathology laboratory, or free-standing radiology center that detects, diagnoses, or treats a cancer case in South Dakota shall submit the information needed on a cancer case to the department or its representative as required by §§ 1-43-11 to 1-43-17, inclusive.

 

          A federal tumor registry may participate in the central cancer registry if the registry submits reports in conformance with the same standards. Any other entity may voluntarily submit any cancer case to the central cancer registry.

 

          Source: 18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32 SDR 69, effective November 7, 2005.

          General Authority: SDCL 1-43-13.

          Law Implemented: SDCL 1-43-13, 1-43-15.

 




Rule 44:22:02:02 Reportable conditions -- General criteria.

          44:22:02:02.  Reportable conditions -- General criteria. The following conditions are reportable:

 

          (1)  Any neoplasm listed in the International Classification of Diseases for Oncology, Third Edition, 2000, with a behavior code of "2", in situ, or "3", malignant, with the exception of:

 

               (a)  Carcinoma in situ of the cervix;

               (b)  Intraepithelial neoplasia of the cervix (CIN) and prostate (PIN); and

               (c)  Basal or squamous cell carcinoma of the non-mucoepidermoid sites of the skin (C44.0-C44.9):

 

                      (i)    8000-8005 Neoplasms malignant (NOS) (C44.0-C44.9);

                      (ii)   8000-8046 Epithelial carcinomas of the skin (C44.0-44.9);

                      (iii)  8050-8084 Papillary and squamous cell carcinomas of the skin (C44.0-C44.9); and

                      (iv)  8090-8110 Basal cell carcinomas of the skin (C44.0-C44.9);

 

          (2)  Any basal and squamous cell carcinoma originating in mucoepidermoid sites: such as the lips (C00.0-C00.9), anus (C21.0), vagina (C52.9), clitoris, labia, vulva (C51.0-C51.9), scrotum (C63.2), or penis (C60.0-C60.9);

 

          (3)  Any vulvar (VIN III), vaginal (VAIN III), and anal (AIN III) intraepithelial neoplasia;

 

          (4)  Any brain and central nervous system tumor, benign or malignant; or

 

          (5)  Any tumor that is not histologically confirmed but with any record that contains any of the following words:

 

apparently

favor

probable

typical of

appears to

favors

suspect

 

comparable with

malignant appearing

suspected

 

compatible with

most likely

suspicious

 

consistent with

presumed

suspicious for

 

 

          However, if the record contains the word "suspicious" and there is no positive biopsy or physician's clinical impression to support the cytology findings, the condition is not reportable.

 

          Source: 18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32 SDR 69, effective November 7, 2005.

          General Authority: SDCL 1-43-13.

          Law Implemented: SDCL 1-43-11, 1-43-13.

 

          Reference: International Classification of Diseases for Oncology, Third Edition, 2000, World Health Organization. Copies may be obtained from the World Health Organization Publications Center, USDA, 49 Sheridan Avenue, Albany, NY 12210. Cost: $54.

 




Rule 44:22:02:03 Repealed.

          44:22:02:03.  Reporting inconclusive diagnoses.Repealed.

          Source: 18 SDR 142, effective March 9, 1992; repealed, 29 SDR 21, effective August 27, 2002.




Rule 44:22:02:04 Repealed.

          44:22:02:04.  Reporting of basal and squamous cell carcinomas of the skin.Repealed.

          Source: 18 SDR 142, effective March 9, 1992; repealed, 29 SDR 21, effective August 27, 2002.




Rule 44:22:02:05 Repealed.

          44:22:02:05.  Standards for determining single and multiple primary tumors. Repealed.

 

          Source: 18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; repealed, 32 SDR 69, effective November 7, 2005.

 




Rule 44:22:02:06 Reportable data elements for tumor registries.

          44:22:02:06.  Reportable data elements for tumor registries. A tumor registry shall report the minimal data elements in the required status table in NAACCR Standards for Cancer Registries, Volume II, for each case which meets the criteria established in §§ 44:22:02:02 to 44:22:02:05, inclusive. These must be reported in the designated NAACCR record layout in NAACCR's Standards for Cancer Registries, Volume II.

 

          Source: 18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32 SDR 69, effective November 7, 2005.

          General Authority: SDCL 1-43-13.

          Law Implemented: SDCL 1-43-13, 1-43-14.

 

          Reference: Standards for Cancer Registries, Volume II, Data Standards and Data Dictionary, North Association of Central Cancer Registries, NAACCR, 2121 W. White Oaks Drive, Suite C, Springfield, IL 62704. Free.

 




Rule 44:22:02:07 Method of reporting for tumor registries.

          44:22:02:07.  Method of reporting for tumor registries. Each facility with a tumor registry shall provide to the department the data elements described in § 44:22:02:06 for all cases which meet the reporting criteria established in §§ 44:22:02:02 to 44:22:02:05, inclusive. Abstracts must be completed within six months from the date of initial diagnosis. Data must be transmitted to the central cancer registry at least on a quarterly basis, by the following dates:

 

First Quarter (January-March)

September 30 of the same year

Second Quarter (April-June)

December 31 of the same year

Third Quarter (July-September)

March 31 of the next year

Fourth Quarter (October-December)

June 30 of the next year

 

          Source: 18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32 SDR 69, effective November 7, 2005.

          General Authority: SDCL 1-43-13.

          Law Implemented: SDCL 1-43-13, 1-43-14.

 




Rule 44:22:02:08 Repealed.

          44:22:02:08.  Method of reporting for manual tumor registries. Repealed.

 

          Source: 18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; repealed, 32 SDR 69, effective November 7, 2005.

 




Rule 44:22:02:09 Method of reporting for pathology laboratories.

          44:22:02:09.  Method of reporting for pathology laboratories. Each pathology laboratory shall submit pathology reports at least on a quarterly basis.

          Source: 29 SDR 21, effective August 27, 2002.

          General Authority:SDCL 1-43-13.

          Law Implemented:SDCL 1-43-11, 1-43-13.




Rule 44:22:02:09.01 Method of reporting for hospitals without tumor registries, physicians, physician assistants, nurse practitioners, nurse midwives, and free-standing radiology centers.

          44:22:02:09.01.  Method of reporting for hospitals without tumor registries, physicians, physician assistants, nurse practitioners, nurse midwives, and free-standing radiology centers. Each provider shall complete a form prescribed by the department if a cancer case is found by the department through case finding mechanisms. The provider shall complete the form and return it to the department within 30 days. If the hospitals, physician, physician assistant, nurse practitioner, nurse midwife, or free-standing radiology center is unable to complete the form, they can provide a copy of that portion of the patient's medical record that contains the minimum information necessary for the department to complete the form. The department may request disease indices from hospitals without tumor registries, physicians, physician assistants, nurse practitioners, nurse midwives, or free-standing radiology centers to assist in case finding. The disease indices shall be provided to the department within 30 days of the request.

 

          Source: 32 SDR 69, effective November 7, 2005.

          General Authority: SDCL 1-43-13.

          Law Implemented: SDCL 1-43-11, 1-43-13.

 




Rule 44:22:02:10 Reporting for other entities.

          44:22:02:10.  Reporting for other entities. The central cancer registry may develop an individual agreement with any entity. The central cancer registry and administration of the entity shall mutually decide how cancer cases will be made available to the central cancer registry.

 

          Source: 29 SDR 21, effective August 27, 2002; 32 SDR 69, effective November 7, 2005.

          General Authority: SDCL 1-43-13.

          Law Implemented: SDCL 1-43-11, 1-43-13.

 

Online Archived History: